NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1367

Display Results as:

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) - PA-16-426

Organization: NCI 

Posting Date: 09-07-2016 

Expiration Date: 09-08-2019 

Activity Code: R01 

Summary: The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection.  

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) - PA-16-425

Organization: NCI 

Posting Date: 09-07-2016 

Expiration Date: 09-08-2019 

Activity Code: R21 

Summary: The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection.  

AHRQ Conference Grant Programs (R13) - PA-16-453

Organization: AHRQ 

Posting Date: 09-29-2016 

Expiration Date: 11-02-2021 

Activity Code: R13 

Summary: The Agency for Healthcare Research and Quality (AHRQ) announces its interest in supporting conferences through the AHRQ Single Year and Multiple Year Conference Grant Programs (R13). AHRQ seeks to support conferences that help to further its mission to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used (http://www.ahrq.gov/funding/policies/foaguidance/index.html. 

AHRQ Grants for Health Services Research Dissertation Program (R36) - PA-15-318

Organization: AHRQ 

Posting Date: 08-04-2015 

Expiration Date: 11-02-2018 

Activity Code: R36 

Summary: This announcement represents the continuation of an AHRQ program that provides support to individuals who are conducting research undertaken as part of an accredited academic program to qualify for a research doctorate degree.  

AHRQ Health Services Research Demonstration and Dissemination Grants (R18) - PA-14-290

Organization: AHRQ 

Posting Date: 07-18-2014 

Expiration Date: 05-26-2018 

Activity Code: R18 

Summary: The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ. 

AHRQ Health Services Research Projects (R01) - PA-14-291

Organization: AHRQ 

Posting Date: 07-18-2014 

Expiration Date: 07-06-2018 

Activity Code: R01 

Summary: The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ. 

AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R01) - PA-15-339

Organization: AHRQ 

Posting Date: 08-28-2015 

Expiration Date: 03-06-2018 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to support investigative research projects that examine the epidemiology of patient safety in ambulatory care settings and long term care facilities, gather evidence about strategies that can improve safety in these settings, and develop evidence-based tools to facilitate implementation of these strategies. 

AHRQ Mentored Clinical Scientist Research Career Development Award (K08) - PA-17-232

Organization: AHRQ 

Posting Date: 03-29-2017 

Expiration Date: 07-13-2022 

Activity Code: K08 

Summary: This funding opportunity announcement (FOA) solicits individual Mentored Clinical Scientist Research Career Development (K08) grant applications from applicant organizations. The overall goal of AHRQ-supported career development programs is to help ensure that a diverse pool of highly trained health services researchers are available in adequate numbers and in appropriate research areas to address the mission and priorities of AHRQ.  

AHRQ Mentored Research Scientist Research Career Development Award (K01) - PA-16-223

Organization: AHRQ 

Posting Date: 05-05-2016 

Expiration Date: 11-12-2019 

Activity Code: K01 

Summary: The primary purpose of the AHRQ Mentored Research Scientist Research Career Development Awards (K01) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, equity, and effectiveness of health care for all Americans. This program represents an AHRQ program to provide support and protected time to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research. The K01 award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances. The K01 award is also available to promote research workforce diversity by providing enhanced research career development opportunities. 

AHRQ Small Research Grant Program (R03) - PA-15-147

Organization: AHRQ 

Posting Date: 03-19-2015 

Expiration Date: 07-17-2018 

Activity Code: R03 

Summary: This FOA encourages Small Research Grant (R03) applications, and expresses AHRQ priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) - PA-18-072

Organization: NIDA 

Posting Date: 11-15-2017 

Expiration Date: 09-08-2018 

Activity Code: R03 

Summary: This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug abuse research on HIV/AIDS. This FOA, AIDS-Science Track Award for Research Transition (A-START), encourages Small Research Grant (R03) applications to support research projects on drug abuse and HIV/AIDS that can be carried out in a short period of time with limited resources. Applications under this FOA are welcomed from all areas of HIV/AIDS research that NIDA supports.  

AIDS-Science Track Award for Research Transition (R03) - PA-15-290

Organization: NIDA 

Posting Date: 09-09-2015 

Expiration Date: 09-08-2018 

Activity Code: R03 

Summary: This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug abuse research on HIV/AIDS. This FOA, AIDS-Science Track Award for Research Transition (A-START), encourages Small Research Grant (R03) applications to support research projects on drug abuse and HIV/AIDS that can be carried out in a short period of time with limited resources. Applications under this FOA are welcomed from all areas of HIV/AIDS research that NIDA supports.  

Academic Research Enhancement Award (Parent R15) - PA-16-200

Organization: NIH 

Posting Date: 04-18-2016 

Expiration Date: 05-08-2019 

Activity Code: R15 

Summary: The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students to meritorious research projects, and to strengthen the research environment of the applicant institution. 

Academic Research Enhancement Award (R15 Clinical Trial Required) - PA-18-343

Organization: NIDCD 

Posting Date: 11-03-2017 

Expiration Date: 01-08-2021 

Activity Code: R15 

Summary: The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students to meritorious research projects, and to strengthen the research environment of the applicant institution. 

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01) - PAR-15-075

Organization: NCI 

Posting Date: 12-16-2014 

Expiration Date: 01-08-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem. The proposed systems may include molecular diagnosis, molecular imaging or related research resources. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate the following examples, among others: (a) current commercially supported systems, (b) next-generation systems, (c) quality assurance and quality control, (d) validation and correlation studies, (e) quantitative imaging, and (f) related research resources. Because applications should be translational in scope, this FOA defines innovation as a coherent translational plan to deliver emerging or new capabilities for preclinical or clinical use that are not yet broadly employed in preclinical or clinical settings. In addition, innovation may be considered as delivery of a new capability to end users. The partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem. This FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work. This FOA does not intend to support either actual commercial production or basic research projects that do not emphasize translation. 

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) - PAR-18-009

Organization: NCI 

Posting Date: 11-01-2017 

Expiration Date: 11-06-2019 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem. 

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01) - PAR-17-093

Organization: NCI 

Posting Date: 12-21-2016 

Expiration Date: 11-06-2019 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) - RFA-CA-17-038

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: UG3/UH3 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. This purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based approaches. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24) - RFA-CA-17-039

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approaches. 

Accelerating Research on Intervertebral Disc (ARID) (R01) - PA-16-097

Organization: NIAMS 

Posting Date: 02-11-2016 

Expiration Date: 03-06-2019 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of grant applications proposing studies on basic biology of the intervertebral disc.The NIAMS invites investigators from all areas of cell biology, bioengineering, and orthopaedic research to consider individual or collaborative efforts to address these needs.Applications that accelerate an understanding of basic research on the intervertebral disc and/or develop new directions on the factors that lead to disc degeneration are particularly encouraged. 

Accelerating Research on Intervertebral Disc (ARID) (R21) - PA-16-096

Organization: NIAMS 

Posting Date: 02-11-2016 

Expiration Date: 03-17-2019 

Activity Code: R21 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of exploratory/developmental grant applications proposing studies on basic biology of the intervertebral disc.The NIAMS invites investigators from all areas of cell biology, bioengineering, and orthopaedic research to consider individual or collaborative efforts to address these needs.Applications that accelerate an understanding of basic research on the intervertebral disc and/or develop new directions on the factors that lead to disc degeneration are particularly encouraged.  

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) - PAR-18-062

Organization: NIDA 

Posting Date: 11-01-2017 

Expiration Date: 05-08-2019 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.  

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) - PAR-16-234

Organization: NIDA 

Posting Date: 05-10-2016 

Expiration Date: 05-08-2019 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.  

Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) - PA-17-143

Organization: NCI 

Posting Date: 01-27-2017 

Expiration Date: 12-13-2017 

Activity Code: (Admin Supp) 

Summary: The National Cancer Institute (NCI) administers two unique programs focused on supporting technology development research that offer transformative potential for advancing cancer research. The Innovative Molecular Analysis Technologies (IMAT) program supports highly innovative, data-generating platforms and methodologies while the Informatics Technologies for Cancer Research (ITCR) program supports powerful data processing and visualization technologies. 

Addressing Chronic Wound Trajectories Through Social Genomics Research (R01 Clinical Trial Optional) - PA-17-492

Organization: NINR 

Posting Date: 09-27-2017 

Expiration Date: 01-08-2021 

Activity Code: R01 

Summary: The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that applies a social genomics approach to chronic wound risk, presence, progression, and healing. The field of social genomics focuses on how the social environment influences gene expression, and how this gene expression may in turn impact health outcomes. Chronic wounds (e.g., diabetic ulcers, venous or arterial ulcers) are multidimensional and, as such, there is benefit to a holistic approach that goes beyond a focus on the wound (i.e., repairing the skin and underlying tissue) to include an approach that focuses on the person with the wound. A better understanding of social environmental factors (positive and negative) and associated molecular mechanisms is needed to advance therapeutic strategies aimed at reducing chronic wound risk in addition to improving healing outcomes and quality of life. 

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top